190 related articles for article (PubMed ID: 1666915)
1. Pharmacological evaluation of halogenated delta 8-THC analogs.
Charalambous A; Lin S; Marciniak G; Banijamali A; Friend FL; Compton DR; Martin BR; Makriyannis A
Pharmacol Biochem Behav; 1991 Nov; 40(3):509-12. PubMed ID: 1666915
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of agonist-antagonist properties of nitrogen mustard and cyano derivatives of delta 8-tetrahydrocannabinol.
Wiley JL; Compton DR; Gordon PM; Siegel C; Singer M; Dutta A; Lichtman AH; Balster RL; Razdan RK; Martin BR
Neuropharmacology; 1996; 35(12):1793-804. PubMed ID: 9076759
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological evaluation of iodo and nitro analogs of delta 8-THC and delta 9-THC.
Martin BR; Compton DR; Semus SF; Lin S; Marciniak G; Grzybowska J; Charalambous A; Makriyannis A
Pharmacol Biochem Behav; 1993 Oct; 46(2):295-301. PubMed ID: 8265683
[TBL] [Abstract][Full Text] [Related]
4. A novel class of potent tetrahydrocannabinols (THCS): 2'-yne-delta 8- and delta 9-THCS.
Ryan W; Singer M; Razdan RK; Compton DR; Martin BR
Life Sci; 1995; 56(23-24):2013-20. PubMed ID: 7776826
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological evaluation of dimethylheptyl analogs of delta 9-THC: reassessment of the putative three-point cannabinoid-receptor interaction.
Martin BR; Compton DR; Prescott WR; Barrett RL; Razdan RK
Drug Alcohol Depend; 1995 Mar; 37(3):231-40. PubMed ID: 7796717
[TBL] [Abstract][Full Text] [Related]
6. Variation of the alkyl side chain in delta 8-THC.
Huffman JW; Lainton JA; Dai D; Jordan RD; Duncan SG
Life Sci; 1995; 56(23-24):2021-4. PubMed ID: 7776827
[TBL] [Abstract][Full Text] [Related]
7. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.
Oviedo A; Glowa J; Herkenham M
Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305
[TBL] [Abstract][Full Text] [Related]
8. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs.
Martin BR; Compton DR; Thomas BF; Prescott WR; Little PJ; Razdan RK; Johnson MR; Melvin LS; Mechoulam R; Ward SJ
Pharmacol Biochem Behav; 1991 Nov; 40(3):471-8. PubMed ID: 1666911
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships for 1',1'-dimethylalkyl-Delta8-tetrahydrocannabinols.
Huffman JW; Miller JR; Liddle J; Yu S; Thomas BF; Wiley JL; Martin BR
Bioorg Med Chem; 2003 Apr; 11(7):1397-410. PubMed ID: 12628666
[TBL] [Abstract][Full Text] [Related]
10. Development of cross-tolerance between delta 9-tetrahydrocannabinol, CP 55,940 and WIN 55,212.
Fan F; Compton DR; Ward S; Melvin L; Martin BR
J Pharmacol Exp Ther; 1994 Dec; 271(3):1383-90. PubMed ID: 7996450
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents.
Compton DR; Johnson MR; Melvin LS; Martin BR
J Pharmacol Exp Ther; 1992 Jan; 260(1):201-9. PubMed ID: 1309872
[TBL] [Abstract][Full Text] [Related]
12. Neurobehavioral effects of delta 9-THC and cannabinoid (CB1) receptor gene expression in mice.
Onaivi ES; Chakrabarti A; Gwebu ET; Chaudhuri G
Behav Brain Res; 1995 Dec; 72(1-2):115-25. PubMed ID: 8788864
[TBL] [Abstract][Full Text] [Related]
13. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.
Janoyan JJ; Crim JL; Darmani NA
Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518
[TBL] [Abstract][Full Text] [Related]
14. Cannabimimetic properties of ajulemic acid.
Vann RE; Cook CD; Martin BR; Wiley JL
J Pharmacol Exp Ther; 2007 Feb; 320(2):678-86. PubMed ID: 17105826
[TBL] [Abstract][Full Text] [Related]
15. Stereochemical effects of 11-OH-delta 8-THC-dimethylheptyl in mice and dogs.
Little PJ; Compton DR; Mechoulam R; Martin BR
Pharmacol Biochem Behav; 1989 Mar; 32(3):661-6. PubMed ID: 2544901
[TBL] [Abstract][Full Text] [Related]
16. Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol.
Compton DR; Gold LH; Ward SJ; Balster RL; Martin BR
J Pharmacol Exp Ther; 1992 Dec; 263(3):1118-26. PubMed ID: 1335057
[TBL] [Abstract][Full Text] [Related]
17. Separation of cannabinoid receptor affinity and efficacy in delta-8-tetrahydrocannabinol side-chain analogues.
Griffin G; Williams S; Aung MM; Razdan RK; Martin BR; Abood ME
Br J Pharmacol; 2001 Jan; 132(2):525-35. PubMed ID: 11159703
[TBL] [Abstract][Full Text] [Related]
18. Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception.
Welch SP; Dunlow LD; Patrick GS; Razdan RK
J Pharmacol Exp Ther; 1995 Jun; 273(3):1235-44. PubMed ID: 7791096
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment.
RodrÃguez de Fonseca F; Gorriti MA; Fernández-Ruiz JJ; Palomo T; Ramos JA
Pharmacol Biochem Behav; 1994 Jan; 47(1):33-40. PubMed ID: 8115426
[TBL] [Abstract][Full Text] [Related]
20. Characterization and autoradiographic localization of the cannabinoid binding site in rat brain using [3H]11-OH-delta 9-THC-DMH.
Thomas BF; Wei X; Martin BR
J Pharmacol Exp Ther; 1992 Dec; 263(3):1383-90. PubMed ID: 1335065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
